SI-BONE/$SIBN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About SI-BONE
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Ticker
$SIBN
Sector
Primary listing
Employees
349
Headquarters
Website
SI-BONE Metrics
BasicAdvanced
$675M
-
-$0.56
0.91
-
Price and volume
Market cap
$675M
Beta
0.91
52-week high
$20.05
52-week low
$11.70
Average daily volume
440K
Financial strength
Current ratio
8.382
Quick ratio
6.865
Long term debt to equity
21.033
Total debt to equity
21.682
Interest coverage (TTM)
-9.18%
Profitability
EBITDA (TTM)
-22.757
Gross margin (TTM)
79.45%
Net profit margin (TTM)
-12.83%
Operating margin (TTM)
-14.90%
Revenue per employee (TTM)
$530,000
Management effectiveness
Return on assets (TTM)
-7.59%
Return on equity (TTM)
-14.18%
Valuation
Price to revenue (TTM)
3.561
Price to book
3.93
Price to tangible book (TTM)
3.93
Price to free cash flow (TTM)
-51.825
Free cash flow yield (TTM)
-1.93%
Free cash flow per share (TTM)
-0.302
Growth
Revenue change (TTM)
22.93%
Earnings per share change (TTM)
-43.75%
3-year revenue growth (CAGR)
24.70%
3-year earnings per share growth (CAGR)
-34.09%
What the Analysts think about SI-BONE
Analyst ratings (Buy, Hold, Sell) for SI-BONE stock.
SI-BONE Financial Performance
Revenues and expenses
SI-BONE Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for SI-BONE stock?
SI-BONE (SIBN) has a market cap of $675M as of August 22, 2025.
What is the P/E ratio for SI-BONE stock?
The price to earnings (P/E) ratio for SI-BONE (SIBN) stock is 0 as of August 22, 2025.
Does SI-BONE stock pay dividends?
No, SI-BONE (SIBN) stock does not pay dividends to its shareholders as of August 22, 2025.
When is the next SI-BONE dividend payment date?
SI-BONE (SIBN) stock does not pay dividends to its shareholders.
What is the beta indicator for SI-BONE?
SI-BONE (SIBN) has a beta rating of 0.91. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.